New method revolutionizes DNA-encoded chemical libraries

Nowadays, there’s lots of buzz about spectacular new medical treatments such as personalised cancer therapy with modified immune cells or antibodies.

CureVac Announces Update to the Management Team – Biotech Investments

Issuer: CureVac / Key word(s): Personnel 14.07.2023 / 13:00 CET/CEST The issuer is solely responsible for the content of this announcement. CureVac Announces Update to

July 15, 2023

Pharmalittle: We’re reading about using Lilly obesity drug to reduce sick days, Sanofi workers striking, and more

Hello, everyone, and how are you today? We are doing just fine, thank you, especially since the middle of the week is upon us. After

October 16, 2024

Biden administration invests $48M in AI/ML platform to identify rare disease drugs

The Biden administration is doling out $48 million to a nonprofit that wants to use machine learning and artificial intelligence to identify potential rare disease

March 1, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.